NCT02164461 2024-05-20
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Advaxis, Inc.
Phase 1 Completed
Advaxis, Inc.
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Pfizer